DongBang Future Tech & Life Co., Ltd is a South Korean pharmaceutical company founded in 1990 that operates as a CDMO for chemical APIs and finished drugs. The company specializes in HPAPI, PROTAC, and hybrid small molecule development, with 35+ active CMC and CDMO projects for global pharma and biotech companies.
HPAPI, PROTAC, Small Molecule API, Chemical API CMC, Hybrid Small Molecules
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.